IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,825,939 | -13.4% | 2,520,731 | 0.0% | 0.75% | -13.8% |
| Q2 2023 | $151,143,031 | +21.3% | 2,520,731 | 0.0% | 0.88% | +29.1% |
| Q1 2023 | $124,624,941 | -13.4% | 2,520,731 | 0.0% | 0.68% | -21.5% |
| Q4 2022 | $143,858,118 | +21.6% | 2,520,731 | 0.0% | 0.86% | +11.5% |
| Q3 2022 | $118,323,000 | +25.8% | 2,520,731 | +0.0% | 0.78% | +45.1% |
| Q2 2022 | $94,048,000 | +24.8% | 2,520,730 | 0.0% | 0.53% | +23.3% |
| Q1 2022 | $75,370,000 | -12.7% | 2,520,730 | 0.0% | 0.43% | +3.1% |
| Q4 2021 | $86,310,000 | -7.6% | 2,520,730 | 0.0% | 0.42% | +2.4% |
| Q3 2021 | $93,443,000 | -5.1% | 2,520,730 | 0.0% | 0.41% | -5.1% |
| Q2 2021 | $98,435,000 | -8.3% | 2,520,730 | 0.0% | 0.43% | -7.1% |
| Q1 2021 | $107,307,000 | – | 2,520,730 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |